新晨動力(01148.HK)與理想汽車(02015.HK)旗下車和家成立合資公司
新晨動力(01148.HK)公布,附屬綿陽新晨與理想汽車(02015.HK)旗下北京車和家成立合資公司四川理想新晨科技有限公司,在獲得其營業執照的前提下,合資公司將主要從事適合新能源汽車的增程式發動機及零件的製造、研發、銷售、售後服務,以及製造其他新能源汽車兼容的汽油發動機。
合資公司的註冊資本總額將為6.3億元人民幣(下同),其中北京車和家將以現金出資3.21億元作為註冊資本,佔51%;綿陽新晨將出資3.09億元作為註冊資本,佔49%,其中8,000萬元以現金出資,而2.29億元將由綿陽新晨通過向合資公司注入出資資產而出資。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.